Osaic Holdings’s Oxford Immunotec Global OXFD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-24,515
Closed -$428K – 7099
2020
Q4
$428K Buy
24,515
+4,971
+25% +$69.7K ﹤0.01% 2796
2020
Q3
$229K Buy
19,544
+5,250
+37% +$69.7K ﹤0.01% 3117
2020
Q2
$186K Buy
14,294
+5,430
+61% +$65.2K ﹤0.01% 3199
2020
Q1
$82K Buy
+8,864
New +$124K ﹤0.01% 3629

Osaic Holdings's OXFD Position: Q1 2021 in Review

Osaic Holdings sold out of Oxford Immunotec Global (OXFD) in Q1 2021, closing a stake of 24,515 shares — an estimated $428K sold.

Osaic Holdings first reported a position in OXFD in Q1 2020 and held it in 4 quarters. The position peaked at $428K in Q4 2020. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.

  • Osaic Holdings reported no remaining Oxford Immunotec Global position as of Q1 2021 after selling out during the quarter.
  • Osaic Holdings sold 24,515 Oxford Immunotec Global shares in Q1 2021, an estimated $428K.
  • Osaic Holdings first reported a position in Oxford Immunotec Global in Q1 2020 and held it in 4 quarters.
  • Osaic Holdings's Oxford Immunotec Global position peaked at $428K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Oxford Immunotec Global as of Q1 2021.

Based on Osaic Holdings's 13F filing for Q1 2021, filed 13 May 2021.